Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system

Identifieur interne : 000072 ( PascalFrancis/Corpus ); précédent : 000071; suivant : 000073

Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system

Auteurs : Marilyn L. Kwan ; LING SHEN ; Julie R. Munneke ; Emily K. Tam ; Paula N. Partee ; Mary Andre ; Susan E. Kutner ; Carol P. Somkin ; Lynn M. Ackerson ; Saskia R. J. Thiadens

Source :

RBID : Pascal:12-0362001

Descripteurs français

English descriptors

Abstract

Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0167-6806
A02 01      @0 BCTRD6
A03   1    @0 Breast cancer res. treat.
A05       @2 135
A06       @2 2
A08 01  1  ENG  @1 Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
A11 01  1    @1 KWAN (Marilyn L.)
A11 02  1    @1 LING SHEN
A11 03  1    @1 MUNNEKE (Julie R.)
A11 04  1    @1 TAM (Emily K.)
A11 05  1    @1 PARTEE (Paula N.)
A11 06  1    @1 ANDRE (Mary)
A11 07  1    @1 KUTNER (Susan E.)
A11 08  1    @1 SOMKIN (Carol P.)
A11 09  1    @1 ACKERSON (Lynn M.)
A11 10  1    @1 THIADENS (Saskia R. J.)
A14 01      @1 Division of Research, Kaiser Permanente Northern California, 2000 Broadway @2 Oakland, CA 94612 @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 8 aut. @Z 9 aut.
A14 02      @1 Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane @2 Walnut Creek, CA 94598 @3 USA @Z 6 aut.
A14 03      @1 San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway @2 San Jose, CA 95119 @3 USA @Z 7 aut.
A14 04      @1 National Lymphedema Network, 116 New Montgomery Street, Suite 235 @2 San Francisco, CA 94105 @3 USA @Z 10 aut.
A20       @1 591-602
A21       @1 2012
A23 01      @0 ENG
A43 01      @1 INIST @2 20699 @5 354000505101070240
A44       @0 0000 @1 © 2012 INIST-CNRS. All rights reserved.
A45       @0 32 ref.
A47 01  1    @0 12-0362001
A60       @1 P
A61       @0 A
A64 01  1    @0 Breast cancer research and treatment
A66 01      @0 NLD
C01 01    ENG  @0 Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.
C02 01  X    @0 002B20E02
C02 02  X    @0 002B12B04
C03 01  X  FRE  @0 Homme @5 01
C03 01  X  ENG  @0 Human @5 01
C03 01  X  SPA  @0 Hombre @5 01
C03 02  X  FRE  @0 Malade @5 02
C03 02  X  ENG  @0 Patient @5 02
C03 02  X  SPA  @0 Enfermo @5 02
C03 03  X  FRE  @0 Connaissance @5 03
C03 03  X  ENG  @0 Knowledge @5 03
C03 03  X  SPA  @0 Conocimiento @5 03
C03 04  X  FRE  @0 Cancer du sein @2 NM @5 04
C03 04  X  ENG  @0 Breast cancer @2 NM @5 04
C03 04  X  SPA  @0 Cáncer del pecho @2 NM @5 04
C03 05  X  FRE  @0 Lymphoedème @5 05
C03 05  X  ENG  @0 Lymphedema @5 05
C03 05  X  SPA  @0 Linfedema @5 05
C03 06  X  FRE  @0 Système santé @5 06
C03 06  X  ENG  @0 Health system @5 06
C03 06  X  SPA  @0 Sistema salud @5 06
C03 07  X  FRE  @0 Soin @5 07
C03 07  X  ENG  @0 Care @5 07
C03 07  X  SPA  @0 Cuidado @5 07
C03 08  X  FRE  @0 Système administration @5 08
C03 08  X  ENG  @0 Delivery system @5 08
C03 08  X  SPA  @0 Sistema administración @5 08
C03 09  X  FRE  @0 Education @5 09
C03 09  X  ENG  @0 Education @5 09
C03 09  X  SPA  @0 Educación @5 09
C03 10  X  FRE  @0 Facteur risque @5 10
C03 10  X  ENG  @0 Risk factor @5 10
C03 10  X  SPA  @0 Factor riesgo @5 10
C07 01  X  FRE  @0 Tumeur maligne @2 NM @5 37
C07 01  X  ENG  @0 Malignant tumor @2 NM @5 37
C07 01  X  SPA  @0 Tumor maligno @2 NM @5 37
C07 02  X  FRE  @0 Cancer @2 NM
C07 02  X  ENG  @0 Cancer @2 NM
C07 02  X  SPA  @0 Cáncer @2 NM
C07 03  X  FRE  @0 Pathologie de la glande mammaire @2 NM @5 38
C07 03  X  ENG  @0 Mammary gland diseases @2 NM @5 38
C07 03  X  SPA  @0 Glándula mamaria patología @2 NM @5 38
C07 04  X  FRE  @0 Pathologie du sein @2 NM @5 39
C07 04  X  ENG  @0 Breast disease @2 NM @5 39
C07 04  X  SPA  @0 Seno patología @2 NM @5 39
C07 05  X  FRE  @0 Pathologie de l'appareil circulatoire @5 40
C07 05  X  ENG  @0 Cardiovascular disease @5 40
C07 05  X  SPA  @0 Aparato circulatorio patología @5 40
C07 06  X  FRE  @0 Pathologie des vaisseaux lymphatiques @5 41
C07 06  X  ENG  @0 Lymphatic vessel disease @5 41
C07 06  X  SPA  @0 Linfático patología @5 41
N21       @1 282
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 12-0362001 INIST
ET : Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
AU : KWAN (Marilyn L.); LING SHEN; MUNNEKE (Julie R.); TAM (Emily K.); PARTEE (Paula N.); ANDRE (Mary); KUTNER (Susan E.); SOMKIN (Carol P.); ACKERSON (Lynn M.); THIADENS (Saskia R. J.)
AF : Division of Research, Kaiser Permanente Northern California, 2000 Broadway/Oakland, CA 94612/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 8 aut., 9 aut.); Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane/Walnut Creek, CA 94598/Etats-Unis (6 aut.); San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway/San Jose, CA 95119/Etats-Unis (7 aut.); National Lymphedema Network, 116 New Montgomery Street, Suite 235/San Francisco, CA 94105/Etats-Unis (10 aut.)
DT : Publication en série; Niveau analytique
SO : Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2012; Vol. 135; No. 2; Pp. 591-602; Bibl. 32 ref.
LA : Anglais
EA : Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.
CC : 002B20E02; 002B12B04
FD : Homme; Malade; Connaissance; Cancer du sein; Lymphoedème; Système santé; Soin; Système administration; Education; Facteur risque
FG : Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques
ED : Human; Patient; Knowledge; Breast cancer; Lymphedema; Health system; Care; Delivery system; Education; Risk factor
EG : Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease
SD : Hombre; Enfermo; Conocimiento; Cáncer del pecho; Linfedema; Sistema salud; Cuidado; Sistema administración; Educación; Factor riesgo
LO : INIST-20699.354000505101070240
ID : 12-0362001

Links to Exploration step

Pascal:12-0362001

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</title>
<author>
<name sortKey="Kwan, Marilyn L" sort="Kwan, Marilyn L" uniqKey="Kwan M" first="Marilyn L." last="Kwan">Marilyn L. Kwan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ling Shen" sort="Ling Shen" uniqKey="Ling Shen" last="Ling Shen">LING SHEN</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Munneke, Julie R" sort="Munneke, Julie R" uniqKey="Munneke J" first="Julie R." last="Munneke">Julie R. Munneke</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tam, Emily K" sort="Tam, Emily K" uniqKey="Tam E" first="Emily K." last="Tam">Emily K. Tam</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Partee, Paula N" sort="Partee, Paula N" uniqKey="Partee P" first="Paula N." last="Partee">Paula N. Partee</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Andre, Mary" sort="Andre, Mary" uniqKey="Andre M" first="Mary" last="Andre">Mary Andre</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kutner, Susan E" sort="Kutner, Susan E" uniqKey="Kutner S" first="Susan E." last="Kutner">Susan E. Kutner</name>
<affiliation>
<inist:fA14 i1="03">
<s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Somkin, Carol P" sort="Somkin, Carol P" uniqKey="Somkin C" first="Carol P." last="Somkin">Carol P. Somkin</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ackerson, Lynn M" sort="Ackerson, Lynn M" uniqKey="Ackerson L" first="Lynn M." last="Ackerson">Lynn M. Ackerson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thiadens, Saskia R J" sort="Thiadens, Saskia R J" uniqKey="Thiadens S" first="Saskia R. J." last="Thiadens">Saskia R. J. Thiadens</name>
<affiliation>
<inist:fA14 i1="04">
<s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0362001</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0362001 INIST</idno>
<idno type="RBID">Pascal:12-0362001</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000072</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</title>
<author>
<name sortKey="Kwan, Marilyn L" sort="Kwan, Marilyn L" uniqKey="Kwan M" first="Marilyn L." last="Kwan">Marilyn L. Kwan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ling Shen" sort="Ling Shen" uniqKey="Ling Shen" last="Ling Shen">LING SHEN</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Munneke, Julie R" sort="Munneke, Julie R" uniqKey="Munneke J" first="Julie R." last="Munneke">Julie R. Munneke</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tam, Emily K" sort="Tam, Emily K" uniqKey="Tam E" first="Emily K." last="Tam">Emily K. Tam</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Partee, Paula N" sort="Partee, Paula N" uniqKey="Partee P" first="Paula N." last="Partee">Paula N. Partee</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Andre, Mary" sort="Andre, Mary" uniqKey="Andre M" first="Mary" last="Andre">Mary Andre</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kutner, Susan E" sort="Kutner, Susan E" uniqKey="Kutner S" first="Susan E." last="Kutner">Susan E. Kutner</name>
<affiliation>
<inist:fA14 i1="03">
<s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Somkin, Carol P" sort="Somkin, Carol P" uniqKey="Somkin C" first="Carol P." last="Somkin">Carol P. Somkin</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ackerson, Lynn M" sort="Ackerson, Lynn M" uniqKey="Ackerson L" first="Lynn M." last="Ackerson">Lynn M. Ackerson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thiadens, Saskia R J" sort="Thiadens, Saskia R J" uniqKey="Thiadens S" first="Saskia R. J." last="Thiadens">Saskia R. J. Thiadens</name>
<affiliation>
<inist:fA14 i1="04">
<s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Breast cancer</term>
<term>Care</term>
<term>Delivery system</term>
<term>Education</term>
<term>Health system</term>
<term>Human</term>
<term>Knowledge</term>
<term>Lymphedema</term>
<term>Patient</term>
<term>Risk factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Homme</term>
<term>Malade</term>
<term>Connaissance</term>
<term>Cancer du sein</term>
<term>Lymphoedème</term>
<term>Système santé</term>
<term>Soin</term>
<term>Système administration</term>
<term>Education</term>
<term>Facteur risque</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0167-6806</s0>
</fA01>
<fA02 i1="01">
<s0>BCTRD6</s0>
</fA02>
<fA03 i2="1">
<s0>Breast cancer res. treat.</s0>
</fA03>
<fA05>
<s2>135</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>KWAN (Marilyn L.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LING SHEN</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MUNNEKE (Julie R.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>TAM (Emily K.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>PARTEE (Paula N.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>ANDRE (Mary)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>KUTNER (Susan E.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>SOMKIN (Carol P.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>ACKERSON (Lynn M.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>THIADENS (Saskia R. J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20>
<s1>591-602</s1>
</fA20>
<fA21>
<s1>2012</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20699</s2>
<s5>354000505101070240</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>12-0362001</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Homme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Human</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Malade</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Patient</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Enfermo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Connaissance</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Knowledge</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Conocimiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Breast cancer</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Système santé</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Health system</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Sistema salud</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Soin</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Care</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Cuidado</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Système administration</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Delivery system</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Sistema administración</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Education</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Education</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Educación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Facteur risque</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Risk factor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Factor riesgo</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Breast disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Seno patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>282</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 12-0362001 INIST</NO>
<ET>Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</ET>
<AU>KWAN (Marilyn L.); LING SHEN; MUNNEKE (Julie R.); TAM (Emily K.); PARTEE (Paula N.); ANDRE (Mary); KUTNER (Susan E.); SOMKIN (Carol P.); ACKERSON (Lynn M.); THIADENS (Saskia R. J.)</AU>
<AF>Division of Research, Kaiser Permanente Northern California, 2000 Broadway/Oakland, CA 94612/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 8 aut., 9 aut.); Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane/Walnut Creek, CA 94598/Etats-Unis (6 aut.); San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway/San Jose, CA 95119/Etats-Unis (7 aut.); National Lymphedema Network, 116 New Montgomery Street, Suite 235/San Francisco, CA 94105/Etats-Unis (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2012; Vol. 135; No. 2; Pp. 591-602; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</EA>
<CC>002B20E02; 002B12B04</CC>
<FD>Homme; Malade; Connaissance; Cancer du sein; Lymphoedème; Système santé; Soin; Système administration; Education; Facteur risque</FD>
<FG>Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques</FG>
<ED>Human; Patient; Knowledge; Breast cancer; Lymphedema; Health system; Care; Delivery system; Education; Risk factor</ED>
<EG>Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Hombre; Enfermo; Conocimiento; Cáncer del pecho; Linfedema; Sistema salud; Cuidado; Sistema administración; Educación; Factor riesgo</SD>
<LO>INIST-20699.354000505101070240</LO>
<ID>12-0362001</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000072 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000072 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:12-0362001
   |texte=   Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024